Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Target

DNA synthesis and repair mechanisms

4 abstracts

Abstract
A phase III, open-label, multicenter, randomized controlled trial of tunlametinib versus investigator-selected chemotherapy in patients with advanced NRAS-mutant melanoma who had previously received immunotherapy.
Org: Drum-Tower Hospital,
Abstract
Phase Ib/II trial of hepatic arterial infusion chemotherapy in combination with fruquintinib for refractory unresectable colorectal cancer liver metastases.
Org: Department of Interventional Therapy,
Abstract
Comparison of clinical outcomes in patients with advanced pulmonary sarcomatoid carcinoma treated with immunotherapy-based regimen or chemotherapy: A study based on the SEER database and multicentric real-world settings.
Org: The Second Affiliated Hospital Of Nanchang University, Nanchang second affiliated hospital, Second Affiliated Hospital of Nanchang University, Department of Oncology and Haematology, Division of Oncology, University Hospital of Modena, Modena, Italy,
Abstract
Non-hematopoietic cell transplant-related veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) in solid tumor and hematologic malignancies: A systematic review.
Org: Xcenda LLC, Jazz Pharmaceuticals, Cedars-Sinai Medical Center,